232
R. López-Moreno et al. / Food Chemistry 152 (2014) 230–236
Table 1
Trifloxystrobin analogues.
evaporation of the solvent was purified by column chromatogra-
phy, using CHCl3 as eluent, affording the NHS-esters in good yield
(60–95%) and in highly pure form, as shown by 1H NMR spectros-
copy (copies of original spectra are included in Supplementary
Data File).
TFa-NHS ester: 86% yield. 1H NMR (300 MHz) d (ppm) 7.87 (1H,
br s, H-200), 7.78 (1H, d, J = 7.8 Hz, H-600), 7.59 (1H, br d, J = 7.8 HZ,
H-400), 7.46 (1H, br t, J = 7.8 Hz, H-500), 7.29 (1H, br s, H-20), 7.20
(1H, dd, J = 7.8, 1.6 Hz, H-60), 7.11 (1H, d, J = 7.8 Hz, H-50), 5.12
(2H, s, OCH2), 4.03 (3H, s, NOCH3), 3.81 (3H, s, CO2CH3), 2.83 (4H,
br s, COCH2CH2CO), 2.67 (2H, t, J = 7.5 Hz, H-6), 2.60 (2H, t,
J = 7.4 Hz, H-2), 2.22 (3H, s, CH3), 1.83–1.65 (4H, m, H-3 and H-
5), 1.49 (2H, m, H-4).
Analogue
R1
R2
R3
TFa-I
TFc-H
TFc-Et
TFf-NO2
TFf-H
CF3
CF3
CF3
NO2
H
CH3
H
C2H5
CH3
CH3
CH3
I
H
H
H
H
H
TFf-NH2
NH2
TFb-NHS ester: 80% yield. 1H NMR (300 MHz) d (ppm) 7.67 (1H,
br s, H-40), 7.59 (1H, br s, H-20), 7.51 (1H, dd, J = 7.6, 1.5 Hz, H-300),
7.46–7.36 (3H, m, H-500, H-60 and H-400), 7.19 (1H, dd, J = 7.4, 1.5 Hz,
H-600), 5.14 (2H, s, OCH2), 4.03 (3H, s, NOCH3), 3.82 (3H, s, CO2CH3),
2.83 (4H, br s, COCH2CH2CO), 2.66 (2H, t, J = 7.3 Hz, H-2), 2.62 (2H,
t, J = 7.4 Hz, H-6), 2.21 (3H, s, CH3), 1.79 and 1.67 (2H each, each m,
H-3 and H-5), 1.47 (2H, m, H-4).
bromo-benzyl derivative. A complete description of the prepara-
tion of these analogues is provided in Supplementary Data File
(Fig. S7).
2.4. Conjugate preparation
TFc-NHS ester: 60% yield. 1H NMR (300 MHz) d (ppm) 7.85 (1H,
br s, H-200), 7.75 (1H, d, J = 7.8 Hz, H-600), 7.59 (1H, d, J = 7.8 Hz, H-
400), 7.51–7.35 (4H, m, H-30, H-40, H-50, and H-500), 7.18 (1H, dd,
J = 7.5, 1.3 Hz, H-60), 5.11 (2H, s, OCH2), 4.03 (3H, s, NOCH3), 3.81
(3H, s, CO2CH3), 2.82 (4H, br s, COCH2CH2CO), 2.75 (2H, t,
J = 7.9 Hz, H-6), 2.55 (2H, t, J = 7.4 Hz, H-2), 1.73 (2H, quint,
J = 7.5 Hz, H-3), 1.56–1.42 (4H, m, H-4 and H-5).
Conjugation was carried out with 1, 5, and 10 lmol of activated
hapten (hapten–NHS ester) and HRP (2.2 mg), OVA (30 mg), and
BSA (15 mg), respectively, in 50 mM carbonate buffer, pH 9.6. For
details see Mercader, Esteve-Turrillas, Agulló, Abad-Somovilla,
and Abad-Fuentes (2012). Protein–hapten conjugates were puri-
fied by gel filtration using 100 mM phosphate buffer, pH 7.4 as elu-
ent, and stored frozen at ꢀ20 °C. Coupling degrees were calculated
at 280 nm from absorbance values before and after conjugation.
TFe-NHS ester: 84% yield. 1H NMR (300 MHz) d (ppm) 7.86 (1H,
br s, H-200), 7.80 (1H, d, J = 7.8 Hz, H-600), 7.59 (1H, d, J = 7.8 Hz, H-
400), 7.48 (1H, m, H-60), 7.46 (1H, m, H-500), 7.42 (1H, m, H-50),
7.37 (1H, m, H-40), 7.18 (1H, dd, J = 7.3, 1.5 Hz, H-30), 5.14 (2H, s,
OCH2), 4.21 (2H, t, J = 6.7 Hz, H-6), 4.02 (3H, s, NOCH3), 2.82 (4H,
br s, COCH2CH2CO), 2.53 (2H, t, J = 7.3 Hz, H-2), 2.23 (3H, s, CH3),
1.73–1.59 (4H, m, H-3 and H-5), 1.44–1.28 (2H, m, H-4).
TFo-NHS ester: 95% yield. 1H NMR (300 MHz) d (ppm) 7.85 (1H,
br s, H-200), 7.79 (1H, d, J = 7.9 Hz, H-600), 7.59 (1H, d, J = 7.8 Hz, H-
400), 7.48 (1H, m, H-60), 7.46 (1H, m, H-500), 7.42 (1H, m, H-50),
7.37 (1H, m, H-40), 7.18 (1H, dd, J = 7.3, 1.5 Hz, H-30), 5.14 (2H, s,
OCH2), 4.25 (2H, t, J = 6.7 Hz, H-6), 3.81 (3H, s, CO2CH3), 2.82 (4H,
br s, COCH2CH2CO), 2.52 (2H, t, J = 7.4 Hz, H-2), 2.22 (3H, s, CH3),
1.68 (4H, m, H-3 and H-5), 1.38 (2H, m, H-4).
2.5. Antibody production
Animal manipulation was carried out in compliance with Span-
ish laws and guidelines (RD1201/2005 and law 32/2007) and
according to European Directive 2010/63EU concerning protection
of animals used for scientific purposes. Each BSA conjugate was
used to immunize a set of female BALB/c mice with 0.1 mg of con-
jugate per animal. Immunogen emulsions were prepared with BSA
conjugates in sterile PBS (10 mM phosphate, pH 7.4 containing
140 mM NaCl) and Freund’s adjuvant. Regular immunization
schedules were followed as previously described (Parra, Mercader,
Agulló, Abad-Somovilla, & Abad-Fuentes, 2012). Ten days after the
third injection, a blood sample was taken by submandibular bleed-
ing. For hybridoma generation, a standard cell fusion protocol was
followed and cells were distributed in 96-well culture microplates
(Mercader et al., 2008a). Selection of the best hybridomas was car-
ried out by a double screening process (Mercader, Suárez-Panta-
león, Agulló, Abad-Somovilla, & Abad-Fuentes, 2008b). Briefly, a
differential ELISA was performed with the supernatant of every
microwell by parallel evaluation of a control well without compet-
itor and a test well with 100 nM trifloxystrobin. Next, those super-
natants exhibiting a clearly lower signal in the test well than in the
control well were reevaluated by a checkerboard competitive
screening test, in which diverse trifloxystrobin concentrations (0,
10, and 100 nM) were tested with serial dilutions of culture super-
natant and different coating concentrations of homologous conju-
gate. Supernatants affording saturated signals in the control well
were also included in this analysis. Hybridomas were cloned twice
by limiting dilution. Antibodies were purified from 100 to 150 mL
culture supernatants by affinity chromatography, and stored at
4 °C as ammonium sulfate precipitates.
TFf-NHS ester: 88% yield. 1H NMR (300 MHz) d (ppm) 7.51 (1H,
dd, J = 7.4, 1.3 Hz, H-300), 7.45–7.34 (4H, m, H-20, H-40, H-400 and H-
500), 7.25 (1H, t, J = 7.7 Hz, H-50), 7.22–7.14 (2H, m, H-600 and H-60),
5.12 (2H, s, OCH2), 4.03 (3H, s, NOCH3), 3.81 (3H, s, CO2CH3), 2.82
(4H, br s, COCH2CH2CO), 2.65–2.58 (2H, two overlapped t,
J = 7.5 Hz, H-2 and H-6), 2.20 (3H, s, CH3), 1.83–1.61 (4H, m, H-3
and H-5), 1.50–1.41 (2H, m, H-4).
TFt-NHS ester: 75% yield. 1H NMR (300 MHz) d (ppm) 7.62 (1H,
t, J = 1.5 Hz, H-20), 7.57–7.47 (2H, m, H-60 and H-300), 7.46–7.33 (3H,
m, H-500, H-400 and H-40), 7.25 (1H, t, J = 7.8 Hz, H-50), 7.18 (1H, dd,
J = 7.4, 1.4 Hz, H-600), 5.12 (2H, s, OCH2), 4.03 (3H, s, NOCH3), 3.82
(3H, s, CO2CH3), 2.84 (4H, br s, COCH2CH2CO), 2.82 (2H, t,
J = 7.4 Hz, H-4), 2.58 (2H, t, J = 7.0 Hz, H-2), 2.18 (3H, s, CH3), 2.06
(2H, quint, J = 7.2 Hz, H-3).
2.3. Synthesis of analogues
A small collection of trifloxystrobin analogues was synthesized,
each one possessing a single structural modification of the triflox-
ystrobin molecule (Table 1). With the exception of TFa-I, an inter-
mediate in the synthesis of hapten TFa, the rest of the analogues
were prepared ex novo from readily available materials via the
same type of strategy used for the preparation of the hapten
framework, which was based on the O-alkylation reaction of a
conveniently functionalized oxime with the appropriated
2.6. Competitive ELISAs
Immunoassays were carried out at room temperature using two
different formats: the antibody-coated direct cELISA and the